Virological biomarkers of HIV remission in children: implications for pediatric cure strategies
Current evidence supports integrated, multi-dimensional virological biomarker strategies rather than reliance on single assays to predict pediatric HIV remission. Harmonization, validation in longitudinal pediatric cohorts, ethical feasibility and further research will be critical to identifying and translating these biomarkers for pediatric cure trials.
Authors
- Kavidha Reddy
- Thumbi Ndung’u
Institutions
- Ragon Institute of MGH, MIT and Harvard (US)
- Africa Health Research Institute (ZA)
- University College London (GB)
- University of KwaZulu-Natal (ZA)
Publication Details
- Journal
- Current Opinion in HIV and AIDS
- Published
- 2026-03-24
- DOI
- https://doi.org/10.1097/coh.0000000000001032
- Primary Topic
- HIV/AIDS drug development and treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00